-
1.
公开(公告)号:US20240398869A1
公开(公告)日:2024-12-05
申请号:US18526459
申请日:2023-12-01
Applicant: University Health Network
Inventor: Gordon Keller , Stephanie Protze , Jee Hoon Lee
Abstract: Methods are disclosed for producing populations of cardiomyocytes from pluripotent stem cells. Populations may be enriched for either atrial or ventricular cardiomyocytes and the resulting ventricular population may be essentially free of pacemaker cells. The method includes incubating pluripotent stem cells in a suitable medium with a BMP component, and an activin component, the amounts of activin may be varied to enrich for either atrial or ventricular cardiomyocytes. The enriched populations, as well as methods of using the same to treat patients in need of cardiac repair are disclosed.
-
公开(公告)号:US11730770B2
公开(公告)日:2023-08-22
申请号:US16737768
申请日:2020-01-08
Applicant: UNIVERSITY HEALTH NETWORK
Inventor: Gordon Keller , Stephanie Protze
CPC classification number: A61K35/34 , C12N5/0657 , C12N5/10 , C12N2501/115 , C12N2501/15 , C12N2501/155 , C12N2501/16 , C12N2501/165 , C12N2501/385 , C12N2501/727 , C12N2501/999 , C12N2506/02 , C12N2506/45
Abstract: Provided are methods for producing compositions comprising a population of cardiomyocytes enriched for or substantially devoid of sinoatrial node-like pacemaker cardiomyocytes (SANLCM) from human pluripotent stem cells (hPSCs), and methods of use thereof.
-
公开(公告)号:US10561687B2
公开(公告)日:2020-02-18
申请号:US15550572
申请日:2016-02-17
Applicant: UNIVERSITY HEALTH NETWORK
Inventor: Gordon Keller , Stephanie Protze
Abstract: Provided are methods for producing compositions comprising a population of cardiomyocytes enriched for or substantially devoid of sinoatrial node-like pacemaker cardiomyocytes (SANLCM) from human pluripotent stem cells (hPSCs), and methods of use thereof.
-
4.
公开(公告)号:US20190336537A1
公开(公告)日:2019-11-07
申请号:US16466278
申请日:2017-12-04
Applicant: UNIVERSITY HEALTH NETWORK
Inventor: Gordon Keller , Stephanie Protze , Jee Hoon Lee
Abstract: Methods are disclosed for producing populations of cardiomyocytes from pluripotent stem cells. Populations may be enriched for either atrial or ventricular cardiomyocytes and the resulting ventricular population may be essentially free of pacemaker cells. The method includes incubating pluripotent stem cells in a suitable medium with a BMP component, and an activin component, the amounts of activin may be varied to enrich for either atrial or ventricular cardiomyocytes. The enriched populations, as well as methods of using the same to treat patients in need of cardiac repair are disclosed.
-
-
-